Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Sue Richards, Nazneen Aziz, Sherri J. Bale et al. · Genetics in Medicine · 2015 · 30.5K citations · Full text

Allelic Variant, Sequence Variants, Medicine +11

CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000

Robert J. Kuczmarski, Cynthia L. Ogden, S. S. Guo et al. · 2002 · 6.5K citations

The United States, Epidemiological Trend, Population Science +9

A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets

Fiona Francis, Steffen Hennig, Bernd Korn et al. · Nature Genetics · 1995 · 1.1K citations

Genetic Disorder, Genetics, X–linked Hypophosphatemic Rickets +3

Burosumab Therapy in Children with X-Linked Hypophosphatemia

Thomas O. Carpenter, Michael P. Whyte, Erik A. Imel et al. · New England Journal of Medicine · 2018 · 449 citations · Full text

RICKETS RESISTANT TO VITAMIN D THERAPY

Fuller Albright · Archives of Pediatrics and Adolescent Medicine · 1937 · 448 citations

Bone Disease, Rheumatology, Health Sciences +15